Leap Investments »

Esperion Therapeutics shares owned by Leap Investments

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Leap Investments from 13F filings

Historical chart of Leap Investments investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Leap Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Leap Investments

Quarter filed Position value Share count Share price at filing
2020-06-30 $210k 4.1k 51.22

More positions owned by Leap Investments

Penn National Gaming Common Stock (PENN)
Crowdstrike Holdings Common Stock (CRWD)
Domino's Pizza Common Stock (DPZ)
Phillips 66 Common Stock (PSX)
Seattle Genetics Common Stock
Discover Financial Services Common Stock (DFS)
Uber Technologies Common Stock (UBER)
Advanced Micro Devices Common Stock (AMD)
Annaly Capital Management Reit
Coca-Cola Co/The Common Stock (KO)
Taiwan Semiconductor Manufacturing Depositary Receipt (TSM)
Western Digital Corp Common Stock (WDC)
Raytheon Technologies Corp Common Stock (RTX)
Ford Motor Common Stock (F)
DexCom Common Stock (DXCM)

View all positions for Leap Investments

Top funds holding Esperion Therapeutics

OrbiMed Advisors
Bellevue Group
Daniel D. Thurber
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Woodline Partners
Millennium Management
D. E. Shaw & Co
Bank of America Corporation
Two Seas Capital
Two Sigma Investments
Meditor
Citadel Advisors
Two Sigma Advisers
Goldman Sachs Group

View all funds holding Esperion Therapeutics